The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis
- PMID: 24658549
- PMCID: PMC6074924
- DOI: 10.5144/0256-4947.2014.12
The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis
Abstract
Background and objectives: Many studies were conducted to assess the relationship between Monoamine oxidase B (MAOB) A644G polymorphism and susceptibility to Parkinson disease (PD). However, the results were inconsistent and inconclusive.
Design and settings: A meta-analysis was conducted from all published studies on the associations between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease.
Methods: In this present study, the possible relationship between MAOB A644G polymorphism and PD risk was assessed by a meta-analysis. Eligible articles were identified for the period up to March 2013. Pooled odds ratios (OR) with 95% confidence intervals (CI) were appropriately derived from fixed-effects models.
Results: Twenty case-control studies with a total of 2846 cases and 3508 controls were eligible. In a recessive model, MAOB A644G polymorphism was associated with PD risk (OR=1.32, 95% CI 1.18-1.47, P < .001). Subgroup analyses by ethnicity and gender also found significant relationships between this polymorphism and PD risk.
Conclusion: This meta-analysis suggested that MAOB A644G polymorphism may be associated with PD development.
Figures





Similar articles
-
Association between monoamine oxidase B A644G polymorphism and Parkinson's disease risk: a meta-analysis in the Chinese population.Genet Mol Res. 2016 Jul 14;15(2). doi: 10.4238/gmr.15028349. Genet Mol Res. 2016. PMID: 27421021
-
MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD.Neurology. 2002 May 14;58(9):1381-7. doi: 10.1212/wnl.58.9.1381. Neurology. 2002. PMID: 12011284
-
A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD.Int J Neurosci. 2016;126(5):400-7. doi: 10.3109/00207454.2015.1028057. Epub 2015 Jul 20. Int J Neurosci. 2016. PMID: 26000819
-
Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson's disease: the impact of ethnicity and onset age.Neurol Sci. 2015 Feb;36(2):179-88. doi: 10.1007/s10072-014-1987-y. Epub 2014 Nov 6. Neurol Sci. 2015. PMID: 25370916 Review.
-
Association between the DRD2 TaqIA gene polymorphism and Parkinson disease risk: an updated meta-analysis.Medicine (Baltimore). 2019 Sep;98(37):e17136. doi: 10.1097/MD.0000000000017136. Medicine (Baltimore). 2019. PMID: 31517853 Free PMC article.
Cited by
-
Androgen receptor and monoamine oxidase polymorphism in wild bonobos.Meta Gene. 2014 Nov 9;2:831-43. doi: 10.1016/j.mgene.2014.10.005. eCollection 2014 Dec. Meta Gene. 2014. PMID: 25606465 Free PMC article.
-
The Role of Single Nucleotide Polymorphisms of Monoamine Oxidase B, Dopamine D2 Receptor, and DOPA Decarboxylase Receptors Among Patients Treated for Parkinson's Disease.J Mol Neurosci. 2022 Apr;72(4):812-819. doi: 10.1007/s12031-022-01966-3. Epub 2022 Jan 19. J Mol Neurosci. 2022. PMID: 35044623 Free PMC article.
-
Contribution of dopaminergic polymorphisms to levodopa treatment response and drug concentration in Chinese patients with Parkinson's disease.Clin Park Relat Disord. 2025 Apr 20;12:100333. doi: 10.1016/j.prdoa.2025.100333. eCollection 2025. Clin Park Relat Disord. 2025. PMID: 40671874 Free PMC article.
-
Polymorphism of the Dopa-Decarboxylase Gene Modifies the Motor Response to Levodopa in Chinese Patients With Parkinson's Disease.Front Neurol. 2020 Oct 29;11:520934. doi: 10.3389/fneur.2020.520934. eCollection 2020. Front Neurol. 2020. PMID: 33250838 Free PMC article.
-
Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration.Front Neurosci. 2016 Aug 22;10:375. doi: 10.3389/fnins.2016.00375. eCollection 2016. Front Neurosci. 2016. PMID: 27597816 Free PMC article. Review.
References
-
- Fritsch T, Smyth KA, Wallendal MS, Hyde T, Leo G, Geldmacher DS. Parkinson Disease: Research Update and Clinical Management. South Med J. 2012;105:650–6. - PubMed
-
- Zimprich A. Genetics of Parkinson’s disease and essential tremor. Curr Opin Neurol. 2011;24:318–23. - PubMed
-
- Langston JW. Epidemiology versus genetics in Parkinson’s disease: progress in resolving an age-old debate. Ann Neurol. 1998;44:S45–S52. - PubMed
-
- Steventon G, Sturman S, Heafield M, Waring R, Napier J, Williams A. Platelet monoamine oxidase-B activity in Parkinson’s disease. J Neural Transm Park Dis Dement Sect. 1989;1:255–61. - PubMed
-
- Kumar MJ, Andersen JK. Perspectives on MAO-B in aging and neurological disease: Where do we go from here? Mol Neurobiol. 2004;30:77–89. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical